Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report
- PMID: 37539362
- PMCID: PMC10396390
- DOI: 10.2176/jns-nmc.2023-0023
Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report
Abstract
Hereditary neuropathy with liability to pressure palsies is an extremely rare genetic disorder; it is an autosomal dominant disorder with a high incidence of neuropathic and/or musculoskeletal pain. A case of achieving pain relief by spinal cord stimulation using differential target multiplexed stimulation for a 44-year-old female patient with hereditary neuropathy with liability to pressure palsies who was experiencing severe pain in her back, face, and all four limbs is presented. In her early teens, the initial symptoms were numbness and weakness of a limb after movement, which improved spontaneously. Transient pain in her back followed by systemic and persistent muscle weakness and pain developed. Deletion of the gene for peripheral myelin protein 22 was detected by peripheral nerve biopsy. The diagnosis of hereditary neuropathy with liability to pressure palsies was made in her early thirties. A spinal cord stimulation trial was performed because her severe pain continued despite administering many medications. Therefore, two spinal cord stimulation systems were implanted at the C3-5 and Th8-9 levels by two procedures. Pain in her back, arms, and legs decreased from 8 to 1, 5 to 1, and 6 to 2 on the numerical rating scale, respectively. Furthermore, opioid usage was tapered. The pain of hereditary neuropathy with liability to pressure palsies has a complicated pathogenesis and is resistant to pharmacological treatment. Spinal cord stimulation using differential target multiplexed stimulation may be a viable treatment option.
Keywords: DTM; hereditary neuropathy with liability to pressure palsies; neuropathic pain; spinal cord stimulation.
© 2023 The Japan Neurosurgical Society.
Conflict of interest statement
The authors have no conflicts of interest directly relevant to this article's content.
Figures



References
-
- de Oliveira AP, Pereira RC, Onofre PT, et al. : Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion. Arq Neuropsiquiatr 74: 99-105, 2016 - PubMed
-
- Dubourg O, Mouton P, Brice A, LeGuern E, Bouche P: Guidelines for diagnosis of hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord 10: 206-208, 2000 - PubMed
-
- Luigetti M, Del Grande A, Conte A, et al. : Clinical, neurophysiological and pathological findings of HNPP patients with 17p12 deletion: a single-centre experience. J Neurol Sci 341: 46-50, 2014 - PubMed
-
- Koehler PJ: Hereditary neuropathy with liability to pressure palsies: the first publication (1947). Neurology 60: 1211-1213, 2003 - PubMed
-
- Chance PF, Alderson MK, Leppig KA, et al. : DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151, 1993 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous